Crossover iliofemoral bypass grafting for treatment of unilateral iliac atherosclerotic disease  by Defraigne, Jean-Olivier et al.
For patients with bilateral atherosclerotic aortoili-
ac disease, aortobifemoral (ABF) bypass grafting is
clearly the optimal method of vascular reconstruction,
now performed with a low operative mortality rate
and excellent long-term patency rates. Nevertheless,
occasionally the atherosclerotic process involving the
iliac axis is unilateral in distribution with minimal to
no symptoms in the contralateral extremity. In these
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Purpose: In patients with unilateral iliac disease, a less invasive procedure than aorto-
bifemoral bypass grafting may be desirable, especially in poor-risk patients or when sex-
ual dysfunction is feared. In these cases, femorofemoral (FF) bypass grafting is often
proposed. Compared with FF bypass grafting, iliofemoral (IF) bypass grafting avoids
bilateral exposure of the groins, which may reduce the risk of infection. When the prim-
itive iliac artery is occluded from its origin or heavily calcified, one may use the con-
tralateral artery as inflow, after a small retroperitoneal exposure, to perform a crossover
iliofemoral (CIF) bypass grafting procedure, through the Retzius space. Our 10-year
experience with CIF bypass grafting in a select group of patients was studied. 
Methods: Between 1986 and 1996, 36 patients underwent CIF bypass grafting for symp-
tomatic unilateral iliac occlusion or stenosis. All patients were examined by means of
Doppler ultrasound scanning and underwent bilateral multiplane angiography. Patients
were considered for this procedure when the ipsilateral common iliac artery was occlud-
ed from its origin or was diffusely and heavily calcified. The decision to perform a CIF
bypass grafting procedure was made when no significant disease of the contralateral
common iliac artery was seen, and patients who had features of contralateral iliac disease
were excluded. The main outcomes were perioperative mortality and morbidity, long-
term primary and secondary patency rates, and limb salvage rate. 
Results: The study included 31 men and five women, with a mean age of 58.8 years.
Indications for bypass grafting were disabling claudication (26 of 36 patients, 72%) and
limb-threatening ischemia (10 of 26 patients, 28%). Twelve procedures were performed
simultaneously: endarterectomy of the recipient common femoral artery (n = 3),
femoropopliteal bypass grafting (n = 4, 11.1%), profundoplasty (n = 4, 11%), and right
internal carotid endarterectomy (n = 1). New postoperative erectile dysfunction did not
develop in any of the patients. The survival rate was 97.3% at 1 year and 68.5% at 5
years. The primary and secondary patency rates were 94% and 100%, respectively, at 1
year and 76.7% and 95%, respectively, at 5 years. The limb salvage rate was 100% at 1
year and 87% at 3 years.
Conclusion: The operative mortality associated with CIF is low. The long-term primary
and secondary patency rates are satisfactory, and they are lower than those reported for
aortobifemoral bypass grafting. This procedure does not preclude a later performance of
an aortobifemoral bypass grafting procedure. CIF bypass grafting is not only suitable
for poor-risk patients with a limited life expectancy who have the appropriate arterial
anatomy, but also may be warranted for young patients in whom erectile dysfunction is
feared. (J Vasc Surg 1999;30:693-700.)
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cases, in which stenoses are not amenable to balloon
angioplasty, and although some authors recommend
performance of an ABF whenever feasible,1 alternate,
less extensive procedures may be desirable. This is the
case, for example, in aged or poor-risk patients or in
younger patients in whom postoperative erectile
impotence is feared. 
In these situations, femorofemoral (FF) bypass
grafting is often performed, and this procedure has
achieved wider acceptance, even for good-risk
patients.2-8 Nevertheless, one of the disadvantages
of FF bypass grafting is the need for a bilateral groin
incision, which has an inherent risk of increased inci-
dence of infection, as emphasized by Szilagyi et al9
and Goldstone et al.10 When the homolateral com-
mon iliac artery is patent, performing a short
iliofemoral (IF) bypass grafting procedure through 
a retroperitoneal approach is another option.11
Compared with FF bypass grafting, IF bypass graft-
ing requires the incision of only one groin, which
may reduce the risk of infection. For example, in
their report comparing FF and IF bypass grafting
procedures, Harrington et al12 noted that wound
complications were significantly more frequent with
FF bypass grafting procedures. This was attributed
to the need for a bilateral approach of the common
femoral artery in the femoral triangle. In the multi-
center study of Ricco et al13 that compared FF and
IF bypass grafting procedures, a similar tendency
and conclusions were reported. Also, some patients
may have had earlier vascular procedures involving
the groin that may make FF bypass grafting more
complicated. 
Nevertheless, in some cases, occlusion of the
primitive iliac artery from its origin or heavy calcifi-
cation may preclude the performance of an ipsilater-
al IF bypass grafting procedure. When the aorta is
also calcified, proximal cross-clamping and anasto-
mosis on the aorta to achieve AF bypass grafting
may be hazardous. In addition, AF bypass grafting
requires more extensive retroperitoneal dissection.
In this case, one alternate procedure may consist of
performing a crossover iliofemoral (CIF) bypass
grafting procedure by using the contralateral iliac
artery for proximal anastomosis after its exposition
by an extraperitoneal approach, the graft being tun-
nelized to the contralateral groin through the
Retzius space to be implanted on the femoral artery.
This retrospective study relates our experience with
CIF bypass grafting procedures performed for uni-
lateral iliac disease and no hemodynamically signifi-
cant disease on the contralateral side in a select
group of patients. 
MATERIALS AND METHODS
The medical records of 36 patients who under-
went a CIF bypass grafting procedure for sympto-
matic unilateral iliac occlusion between January 1986
and December 1996 at the Vascular Department of
the University of Liege were reviewed. All the proce-
dures were performed electively for chronic obstruc-
tive arterial disease, and bypass grafting procedures
performed for acute ischemic disease were excluded
from the study. Hospital records were analyzed to
document operative mortality and morbidity and pri-
mary and secondary patency rates. Clinical data were
classified according to standards recommended by
the Society for Vascular Surgery and the North
American Chapter of the International Society for
Cardiovascular Surgery. Limb-threatening ischemia
was defined as gangrene, ischemic ulceration, or rest
pain with an ankle brachial pressure index of less than
0.4 or a barely pulsatile pulse volume recording. 
All patients underwent retrograde femoral bilat-
eral multiplane angiography. Patients were consid-
ered for this procedure when the ipsilateral common
iliac artery was occluded from its origin or was dif-
fusely and heavily calcified. Choice of the procedure
was determined by means of the patient’s overall
medical condition, combined with noninvasive and
angiographic evaluations and the surgeon’s prefer-
ence. The decision to perform a CIF bypass grafting
procedure was made when no significant disease of
the contralateral common iliac artery was seen, and
patients with features of contralateral iliac disease
(mural calcifications or stenosis) were excluded. 
Perioperative morbidity and mortality were
defined as events occurring within 30 days of opera-
tion. After being discharged from the hospital, the
patients were periodically observed with serial clinical
examination and noninvasive vascular testing per-
formed by one of the surgeons or, rarely, by outside
physicians with whom we communicated. The fol-
low-up period ranged from 1 to 144 months, with a
mean follow-up period of 45 months. Determination
of graft patency was made with maintenance of
Doppler pressure measurements, the surgeon’s pal-
pation of a pulse, or, in some cases, angiography
when clinically indicated. A graft was considered to
have primary patency when it had uninterrupted
patency, with either no procedure performed on it or
a procedure, such as transluminal dilation or proxi-
mal or distal extension to the graft, performed to deal
with disease progression in the adjacent native vessel.
A graft was considered to have secondary patency
when patency was restored after occlusion by means
of thrombectomy, thrombolysis, or transluminal
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angioplasty and when the graft itself or one of its
anastomoses required revision to maintain patency.
In the subgroup of patients admitted for limb-threat-
ening ischemia, limb salvage was defined by the
absence of major amputation during the follow-up
period. Bypass grafts that were demonstrated to be
patent by the above methods and in which the limb
was amputated were regarded as open. Primary and
secondary patency rates, the limb salvage rate, and
the survival curve were estimated by means of the life
table method. Standard error was computed by
means of the method suggested by Peto et al14 and
Rutherford et al.15
Patients and clinical presentation. The demo-
graphic characteristics of the patients are summarized
in Table I. There were 31 men (86%) and five women
(14%), with an average age of 58.8 years (range, 41
to 82 years). Sixteen patients were younger than 55
years. Twenty-four patients were smokers, nine
patients had known ischemic heart disease, five
patients had previous myocardial infarctions, and 
six patients had angina pectoris. Eight patients 
had chronic obstructive bronchopneumopathy. Six
patients had diabetes mellitus, and 10 patients had
hypertension. Other conditions included cerebrovas-
cular disease (n = 1), hypercholesterolemia (n = 4),
and nephrotic syndrome (n = 1). Eight patients had
10 previous vascular procedures, as listed in Table II:
coronary artery bypass grafting (n = 1), abdominal
aortic endarterectomy (n = 2), bilateral common
femoral endarterectomy (n = 1), bilateral (n = 2) or
contralateral (n = 1) femoropopliteal bypass grafting,
homolateral primitive iliac artery transluminal bal-
loon angioplasty (n = 2), and superficial femoral
artery angioplasty (n = 1). Two of these patients had
multiple procedures. There were earlier revasculariza-
tions involving groin dissections in four patients
(11.1%), three of which involved the contralateral
side. These three patients were considered to have
“hostile” groins, and therefore CIF bypass grafting
was attempted. The indications for bypass grafting
were severe disabling claudication (26 of 36 patients,
72%) and limb-threatening ischemia (n = 10, 28%),
with rest pain in six patients (16.6%) and ulcer or
gangrene in four patients (11.1%). 
The left lower limb was involved in 24 cases
(66%), and the right lower limb was involved in 12
cases. The stenosis or the occlusion was located at
the level of the common iliac artery in 28 cases, at
the level of the external iliac artery in three cases,
and involved both the common and the external iliac
arteries in five cases. In 17 cases, distal lesions ipsi-
lateral to the diseased iliac artery were noted: deep
femoral artery stenosis (n = 2), stenosis or occlusion
of the superficial femoral artery (n = 14), and com-
bined deep and superficial femoral arteries stenosis
(n = 1). The superficial femoral artery (SFA) was
totally occluded in 12 cases and stenosed (more than
70%) in three cases. Clinical indications for the CIF,
instead of AF, bypass grafting procedure were high
surgical risks in 28 patients (previous myocardial
infarction [n = 5], angor pectoris [n = 6], obesity [n
= 3], chronic obstructive bronchopneumopathy [n =
8], hostile groins [n = 3], advanced age [n = 5]),
and, in the eight remaining male patients, prophy-
laxis of sexual dysfunction, often reported to be a
consequence of conventional aortoiliac surgery. 
Operation. The procedures were performed
with general anesthetic (n = 25, 70%) or spinal anes-
thetic (n = 11, 30%). Prophylactic antibiotics and
intravenous heparin therapy (1 mg/kg) were used
routinely before clamping. The exposure of the
donor iliac artery was achieved with a median sub-
ombilical or lateral extraperitoneal approach,
through an oblique lower quadrant incision, with
the medial portion just below the umbilicus (Fig 1).
The common femoral artery and its bifurcation were
exposed via vertical groin incisions. The site of the
proximal anastomosis was always the common iliac
artery contralateral to the symptomatic limb, and
the proximal anastomosis was constructed on a ter-
minolateral way. In one case, proximal endarterecto-
my of the donor iliac artery was performed. Dacron
that was 8 mm in diameter was used as the conduit
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Table I. Demographic characteristics
Average age (years) 58.8
Men/Women (%) 86/14
Diabetes mellitus (%) 16
Hypertension (%) 27
Coronary disease (%) 25
Smoking (%) 66
Hypercholesterolemia (%) 11
Cerebrovascular disease (%) 3
Nephrotic syndrome (%) 3
Chronic pulmonary obstructive disease (%) 14
Table II. Previous vascular procedures
Abdominal aortic endarterectomy 2
Common femoral artery endarterectomy 1
Primitive iliac artery balloon angioplasty 2
Femoropopliteal bypass grafting 5
Coronary grafting 1
Superficial femoral artery angioplasty 1
in 34 patients (94%), and 8-mm polytetrafluoroeth-
ylene was used in two patients. The bypass graft was
placed in the Retzius space and tunneled behind the
inguinal ligament. 
Twenty-five (70%) of the grafting procedures
were performed as solitary procedures, and 12
(30%) were performed synchronously with other
procedures in 11 patients. Associated procedures
included endarterectomy of the recipient common
femoral artery (n = 3), femoropopliteal bypass graft-
ing (n = 4, 11.1%), profundoplasty (n = 4, 11%), and
right internal carotid endarterectomy (n = 1).
Profundoplasty was performed routinely in case of
stenosis of the deep femoral artery. The decision to
perform concomitant distal revascularization was
made by the surgeon, based on the severity of the
infrainguinal arterial disease, the patient symptoms,
the overall medical condition, and the surgeon’s
expectation that an inflow procedure alone would
not completely relieve the patient’s symptoms. The
femoropopliteal bypass grafting procedures were
performed for severe claudication in two cases and
for rest pain or ulcer in two cases. 
Postoperative morbidity and mortality. The
operative mortality rate was 3.3%. One patient died of
mesenteric infarction in the postoperative period,
despite undergoing a small bowel resection. Nonlethal
complications included myocardial infarction (n = 1),
transient renal failure (n = 1), and pulmonary compli-
cations (n = 3). In five cases, minor complications,
including hematomas and superficial wound infec-
tions, were noted. None of the eight patients in whom
prevention of erectile dysfunction was the indication
complained of impotence. 
Long-term survival, patency rates, and limb
salvage rate. During the follow-up period, two
patients were lost to follow-up, and eight died from
various causes. Three deaths were related to vascular
disease (one cerebrovascular accident and two
myocardial infarctions). Two patients died of
unknown causes. The three remaining patients died
of miscellaneous causes (pneumonia [n = 1],
Alzheimer’s disease [n = 1], and cirrhosis [n = 1]).
Among the patients who died, four patients had ini-
tially had a homolateral SFA totally occluded (n = 3)
or stenosed (n = 1). All the patients who died were
asymptomatic at the time of death. The survival rates
were 97.3% and 68.5% at 1 and 5 years, respectively
(Fig 2).
One graft, performed in a patient admitted for
limb-threatening ischemia, occluded at the fourth
postoperative day because of poor runoff and was sal-
vaged with thrombectomy and completion of a
femoropopliteal bypass grafting procedure. One graft
occluded after 15 days and was also treated with
thrombectomy and addition of a femoropopliteal
bypass grafting procedure. Both of these patients had
preoperative occlusion of the SFA. One of these
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Fig 1. Schematic of the crossover iliofemoral bypass
grafting procedure. 
Fig 2. Cumulative survival rate. The dotted line indicates
standard error higher than 10%.
patients underwent above-knee amputation after 22
months because of graft failure. Two patients who
initially had totally occluded SFAs underwent subse-
quent femoropopliteal bypass grafting procedures
because of recurrence of severe claudication. These
two patients are asymptomatic 13 and 57 months
later. In one instance, progressive stenotic disease of
the donor iliac artery was treated successfully with
balloon angioplasty after 24 months, and this patient
remained asymptomatic 6 months later. One patient
underwent a contralateral femoropopliteal bypass
grafting procedure 36 months after completion of
the CIF bypass grafting procedure. No thrombosis
was observed in the group of patients with patent
SFAs. No kinking over the route of the graft or prob-
lems with the proximal anastomosis were observed
during the follow-up period. Thus, the primary
patency rates at 1 and 5 years (Fig 3) were 94% and
76.7%, respectively. The secondary patency rates (Fig
3) at 1 and 5 years were 100% and 95%, respectively.
The limb salvage rates for the patients admitted with
limb-threatening ischemia (Fig 4) were 100% at 1
year and 87% at 3 years. 
DISCUSSION
Although ABF bypass grafting remains the gold
standard for the treatment of iliac disease, occasional-
ly localized disease, other clinical factors, or both may
make unilateral reconstruction more desirable, partic-
ularly in high-risk patients or when postoperative sex-
ual dysfunction is feared. When the occlusive disease
is confined to one iliac artery and when the contralat-
eral iliac artery is functionally patent, the FF graft is
often chosen.2-8 The disadvantage of the FF bypass
grafting procedure is that it requires bilateral dissec-
tion of the groins, which increases the risk of infec-
tion, especially in obese or poor-risk patients, with
possible extension to the prosthesis. Homolateral, IF
bypass grafting avoids such bilateral exposure, which
may reduce the risk of infection. In fact, in the study
of Harrington et al12 that compared FF and IF bypass
grafting procedures, the incidence of wound infec-
tions was significantly higher in the FF group (11 of
162 patients, 6.7%) than the IF group (1 of 82
patients, 1.2%). Similar results were observed in a
cooperative study reported by Ricco et al13, in which
the incidence of wound infections, problems, or both
was significantly increased in the FF group (13.4%)
versus the IF group (1.4%). Moreover, although there
is potential morbidity inherent to retroperitoneal dis-
section, IF grafts may have additional theoretical
advantages. Compared with the FF grafts, the IF
bypass graft is placed more deeply and is more cush-
ioned, with a more anatomical route. In addition, as
in the case of three of our patients, some patients may
have previous vascular surgery involving the con-
tralateral groins with adhesions, thus complicating
performance of FF bypass grafting. To avoid groin
reexposure in these three patients, FF bypass grafting
was not considered. 
However, indications of homolateral IF bypass
grafting may be limited in some circumstances. For
example, when the primitive iliac axis is heavy calcified
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Fig 3. Cumulative primary and secondary patency rates.
The dotted line indicates standard error higher than 10%.
Fig 4. Cumulative limb salvage rate. The dotted line indi-
cates standard error higher than 10%.
or occluded from its origin, the proximal anastomosis
should be constructed on the aortic bifurcation to
perform an AF bypass grafting procedure. This latter
procedure requires more extensive retroperitoneal
dissection, which may be cumbersome in obese or
poor-risk patients or may risk male sexual dysfunction
consecutive to extensive retroperitoneal dissection in
a young patient. This latter consideration dictated our
choice in eight patients. CIF bypass grafting also
requires vascular procedures on the unaffected side as
does FF bypass grafting, but it avoids bilateral expo-
sure of the groins. Proximal anastomosis for CIF
bypass grafting may be performed with a lateral
retroperitoneal approach or with a midline extraperi-
toneal approach, as described for the treatment of
bilateral inguinal hernias. We favor this later approach
in patients who are not obese. The graft is then placed
in the Retzius space and follows a well-adapted curve
from the proximal anastomosis to the contralateral
femoral artery. This procedure burns no bridges, and
failure of CIF bypass graft in a young, good-risk
patient can readily be managed later with a conversion
to ABF bypass graft. 
All the above considerations influenced our
choice of CIF bypass grafting in selected patients. In
our patients, CIF bypass grafting was considered
only when no signs of significant atherosclerotic dis-
ease of the contralateral common iliac artery were
noted by means of careful examination of the preop-
erative arteriography. In our series, an asymmetrical
distribution of iliac artery occlusive disease was
observed; the left lower limb was more frequently
involved, as was reported by other studies. In symp-
tomatic iliac disease, absence of contralateral iliac
lesions is rare, and our group of patients is a very
select one, because during the same period, we per-
formed 1499 ABF bypass grafting procedures. As for
FF bypass grafting, the identification of a satisfacto-
ry inflow source is of prime importance when plan-
ning crossover bypass grafting procedures. Single
plane arteriography may underestimate the extent
and the severity of aortoiliac atherosclerosis.16,17
Poorer patency rates have been reported for IF
bypass grafting when proximal endarterectomy is
needed,11,18,19 and, when necessary, an alternative
method of revascularization should be considered.
CIF bypass grafting was considered only when no
signs of significant atherosclerotic disease of the con-
tralateral common iliac artery were noted on careful
examination of the preoperative arteriography with
biplane and oblique projections. As a consequence,
in our series, only one endarterectomy of the donor
iliac artery was required. This graft, however,
remained patent until the death of the patient 8
months later. In the follow-up period, only one graft
failure was attributed to a proximal problem on the
donor iliac artery, which was treated with balloon
angioplasty. When planning FF bypass grafting in
the presence of donor iliac artery stenosis, some
authors proposed to perform iliac balloon angioplas-
ty before completion of the FF bypass graft.16,19
This seems to us inadequate in the case of CIF
bypass grafting, because the site of angioplasty must
be exposed, and, in addition, when stenting is nec-
essary, this complicates the proximal anastomosis. 
Concerns also exist that disease progression in
the aorta or in the contralateral iliac artery will
necessitate later reoperation in a significant percent-
age of patients, as occurred in the series of Levinson
et al,20 in which surgery on the contralateral aortoil-
iac system was required in 17% of the patients who
received unilateral grafts. Because of this potential
atheromatous evolution, Piotrowski et al1 rejected
all unilateral direct or crossover revascularization
procedures, preferring instead to perform an ABF
bypass grafting procedure for apparently isolated
unilateral iliac stenosis. This policy is probably
extreme, because in our series, only one patient had
graft failure because of a proximal problem and
required later balloon angioplasty of the donor iliac
artery. In a similar manner, in the study of Ricco et
al,13 stenosis on the donor iliac artery occurred only
in 5.4% of the patients who had undergone
crossover bypass grafting. Plecha and Plecha21
reported their 10-year experience with 113 patients
who received FF bypass grafts and found only one
patient in whom there was significant progression of
the occlusive disease in the iliac artery on the donor
side. Nevertheless, our group of patients constitute
a very select one, as shown at the 5-year follow-up,
when the cumulative survival rate (68%) was lower
than the primary patency rate (76.7%). The potential
deterioration of the donor iliac artery should be
taken into account in the case of a young patient in
whom close surveillance of the native iliac take-off
artery is mandatory, but the problem may be less
important in a poor-risk patient with a limited life
expectancy. 
Conversely, an increased blood flow through the
donor iliac artery has been demonstrated after FF
bypass grafting.22 This may delay the progression of
the arterial occlusion, partly because the intimal
hyperplasia inversely correlates with blood flow and
shear stress. In addition, in patients receiving FF
bypass grafts, Da Gama23 demonstrated an increase
in diameter of both donor side external and com-
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mon femoral arteries, resulting from a change in the
intrinsic strength and structural integrity of the arte-
rial wall after the increased blood flow caused by
diminished peripheral resistance. This may compen-
sate for atherosclerotic stenosis in the donor vessel,
thereby contributing to the preservation of the
patency of the donor artery and the permeability of
the grafts. This phenomenon may also be relevant in
the case of CIF bypass grafting. 
CIF bypass grafts are extraanatomic bypass grafts,
and, as a consequence, like other extraanatomic
bypass grafts, they are more largely adversely affected
by poor runoff than ABF bypass grafts. Adequacy of
runoff influences patency, and the main cause of fail-
ure after IF or FF bypass grafting procedures is likely
poor runoff, not progressive proximal disease.3,6 For
example, the striking effect of SFA occlusion on the
patency of FF bypass grafts has been emphasized.23 In
the study of Brener et al,24 the presence of a patent
SFA improved the success of the FF bypass graft (68%
vs 45%). In our series, the small number of patients
precludes definite conclusions. Nevertheless, no
occlusion occurred in the patients with patent SFA at
the time of CIF bypass grafting completion, and addi-
tional procedures were required in the patients with
SFA occlusion. Four of the six primary failures were
observed in the group of patients with homolateral
SFA disease. The life expectancy of the patient at the
time of completion of the procedure should also be
considered in the perspective of occlusion of the CIF
bypass graft because of poor-runoff. For instance, in
our young male patients, when fear of sexual dysfunc-
tion was the main indication, CIF bypass grafting was
performed only when both the deep and superficial
femoral arteries were patent. 
When an IF graft is inserted in the presence of an
occluded SFA, the long-term patency appears to be
compromised sufficiently to suggest that graft flow
should be increased by adding a femoropopliteal
bypass graft.25 In the series of Couch et al,18 a lower
patency rate for IF grafts was observed when only the
profunda femoris artery was patent, compared with
patency of both the profunda and the superficial
femoral arteries. In our series, femoropopliteal bypass
grafting was not systematic and was performed only
when the profunda femoral artery did not appear
adequate at the time of completion of the CIF bypass
graft and when it seemed to the surgeon that pro-
fundaplasty alone would not be sufficient. As stated
by several authors, careful attention should be paid to
ensure adequate profunda femoris artery outflow,
when the superficial femoral artery is occluded.26-28
In the series of Kalman et al,4 a profundoplasty was
systematically performed in presence of deep femoral
artery stenosis. No significant difference in patency
rate was observed when patients were stratified
according to the performance or nonperformance of
a profundaplasty, whether the SFA was patent or not.
An aggressive approach to the profunda femoris
artery when the femoral superficial artery is occluded
is therefore mandatory to improve the mid- and
long-term results. 
A precise comparison of our results with those of
the literature is difficult, because large variations in
the reported results exists. Several causes may
explain these differences: patient selection (mixing
of poor- and good-risk patients, bypass grafting
reserved for poor-risk patients, or performed as a
matter of preference), symptoms, and differences in
run-off. All these factors may significantly affect
long-term patency and mortality rates. For example,
by excluding the patients at highest risk from trans-
abdominal reconstruction, one tends to improve the
results of ABF bypass grafting procedures and end
up having a paradoxically higher operative mortality
rate for the lower-risk extraanatomic bypass grafting
procedures. The method of reporting the patency
rates may also influence the results. In our series,
every graft that was maintained open by means of
thrombectomy, angioplasty, anastomotic revision, or
additional procedure was considered occluded. We
stringently followed the criteria for patency estab-
lished by the Society for Vascular Surgery and the
North American Chapter of the International
Society for Cardiovascular Surgery.12 Keeping in
mind that the survival rate in this series is limited
and that our patients constitute a very select group,
our primary and secondary patency rates (76.7% and
95%, respectively, at 5 years) compare favorably with
some reports of the literature. For homolateral IF
bypass grafting, Harrington et al12 reported a 5-year
patency rate of 74.9%, Kalman et al11 reported a 92%
patency rate at 3 years, and Couch et al18 reported a
77% patency rate at 4 years. For patients undergoing
iliac balloon angioplasty and FF bypass grafting,
Walker et al16 reported an 81% patency rate after 3
years. The patency rate reported here is higher than
those reported by several authors for FF bypass
grafting.4,6,29
In conclusion, CIF bypass grafting is easy to per-
form through a small retroperitoneal approach.
Compared with FF bypass grafting, it avoids bilater-
al exposure of the groins, in which the risk of infec-
tion is increased and which may be cumbersome in
presence of previous vascular procedures involving
the contralateral femoral triangle. The operative
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mortality associated to CIF is low. The long-term
primary and secondary patency rates are satisfactory.
Finally, this procedure does not preclude later per-
formance of an ABF bypass grafting procedure. CIF
bypass grafting is not only suitable for poor-risk
patients with a limited-life expectancy who have the
appropriate arterial anatomy, but also may be war-
ranted for young patients with a good runoff and in
whom erectile dysfunction is feared.
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